These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4912962)

  • 1. Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine.
    Perry HM; Tan EM; Carmody S; Sakamoto A
    J Lab Clin Med; 1970 Jul; 76(1):114-25. PubMed ID: 4912962
    [No Abstract]   [Full Text] [Related]  

  • 2. Antinuclear antibodies following hydralazine toxicity.
    Condemi JJ; Moore-Jones D; Vaughan JH; Perry HM
    N Engl J Med; 1967 Mar; 276(9):486-91. PubMed ID: 4959828
    [No Abstract]   [Full Text] [Related]  

  • 3. Prospective study of immunologic effects of hydralazine in hypertensive patients.
    Litwin A; Adams LE; Zimmer H; Foad B; Loggie JH; Hess EV
    Clin Pharmacol Ther; 1981 Apr; 29(4):447-56. PubMed ID: 6970646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antinuclear antibodies and lupus induced during treatment of arterial hypertension. Role of beta-blockers and alpha-methyldopa].
    Homberg JC; Abuaf N; Plouin PF; Ménard J; Fillastre JP
    J Pharmacol; 1983; 14 Suppl 2():61-6. PubMed ID: 6138472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrallazine in hypertension: is there a safe dose?
    Bing RF; Russell GI; Thurston H; Swales JD
    Br Med J; 1980 Aug; 281(6236):353-4. PubMed ID: 6968614
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug therapy. Hydralazine.
    Koch-Weser J
    N Engl J Med; 1976 Aug; 295(6):320-3. PubMed ID: 778618
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-induced lupus: clinical and serological studies.
    Harmon CE; Portanova JP
    Clin Rheum Dis; 1982 Apr; 8(1):121-35. PubMed ID: 6811188
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphocytotoxic antibodies in hydralazine-induced lupus erythematosus.
    Ryan PF; Hughes GR; Bernstein R; Mansilla R; Dollery CT
    Lancet; 1979 Dec; 2(8154):1248-9. PubMed ID: 92663
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydralazine and lupus nephritis.
    Ihle BU; Whitworth JA; Dowling JP; Kincaid-Smith P
    Clin Nephrol; 1984 Nov; 22(5):230-8. PubMed ID: 6240359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydralazine-associated glomerulonephritis.
    Björck S; Svalander C; Westberg G
    Acta Med Scand; 1985; 218(3):261-9. PubMed ID: 3907285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydralazine, antinuclear antibodies, and the lupus syndrome.
    Mansilla-Tinoco R; Harland SJ; Ryan PJ; Bernstein RM; Dollery CT; Hughes GR; Bulpitt CJ; Morgan A; Jones JM
    Br Med J (Clin Res Ed); 1982 Mar; 284(6320):936-9. PubMed ID: 6802356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of immune response to hydralazine and development of antideoxyribonucleoprotein in patients receiving hydralazine.
    Carpenter JR; McDuffie FC; Sheps SG; Spiekerman RE; Brumfield H; King R
    Am J Med; 1980 Sep; 69(3):395-400. PubMed ID: 6968159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute immunologic hydralazine reaction. Clinical and serological changes after hydralazine administration to a patient with circulating antinuclear antibodies.
    Alarcón-Segovia D
    Rev Invest Clin; 1972; 24(2):167-74. PubMed ID: 4538312
    [No Abstract]   [Full Text] [Related]  

  • 14. [Frequency of hematologic side effects in antihypertensive long-term therapy].
    Jung D; Teichmann G; Wulff E
    Z Gesamte Inn Med; 1973 Feb; 28(4):58-60. PubMed ID: 4633733
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antinuclear antibodies in patients with rheumatoid arthritis].
    Wranicz A; Budźko T
    Pol Tyg Lek; 1970 Oct; 25(42):1570-3. PubMed ID: 4920352
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antinuclear antibodies in defined or classical rheumatoid disease of the adult].
    Cossermelli W; Leser PG; Gomide WS; Maspes V
    Rev Hosp Clin Fac Med Sao Paulo; 1980 Aug; 35(4):194-8. PubMed ID: 6161407
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical significance of anticytoplasmic antibodies found on fluorescent antinuclear antibody testing.
    Tesser JR; Rothberger H; Agudelo C
    J Rheumatol; 1983 Apr; 10(2):227-34. PubMed ID: 6345769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic effects of hydralazine in hypertensive patients.
    Litwin A; Adams LE; Zimmer H; Hess EV
    Arthritis Rheum; 1981 Aug; 24(8):1074-8. PubMed ID: 6974554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Demonstration of antinuclear factors using indirect immunofluorescence in scleroderma patients].
    Nebe H; Blume N
    Dermatol Monatsschr; 1971 Jan; 157(1):27-31. PubMed ID: 4938251
    [No Abstract]   [Full Text] [Related]  

  • 20. [Organ-non-specific antinuclear antibodies. Demonstration in titration of human fibroblasts and with a single graduating of fluorescence intensity in rat liver sections].
    Kristensen FB; Høier-Madsen M; Møller S
    Ugeskr Laeger; 1982 Jun; 144(25):1845-8. PubMed ID: 6753291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.